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Abstract
Secondary neutrons are unwanted byproduct in proton radiotherapy. Exposure due to secondary neutrons in proton radiother-
apy could cause a significant risk for developing a secondary cancer later in the patient lifetime. The level of exposure due to
secondary neutrons primarily depends on the type of beam delivery system used to deliver the primary proton dose. Although
the patient body can produce significant neutrons but since these neutron are created inside the human body, their exposure is
unavoidable. This report briefly discusses the type of beam delivery systems currently in use in proton radiotherapy, a relative
comparison of neutron exposure in each case, and the importance of neutron study in proton radiotherapy.
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In 1946, Robert Wilson first suggested that the beams of ener-
getic protons can be employed in the treatment of cancer.1
This is because the relatively larger mass of proton compared
to x-rays and electrons would cause less scattering, and the
greater energy deposition of protons at the end of their range
would allow highly localized irradiation. The property of
Bragg peak enabled proton therapy to be a superior modality in
certain cases compared to conventional MV X-ray (photon)
radiotherapy.2 However, the conformity of dose is achieved by
passing proton beams through various materials inside the
beam delivery system and this result in the production of sec-
ondary neutrons. The basic mechanism of neutron production
is the non-elastic interactions of energetic protons with atomic
nuclei of the interacting media.3-4 The energy of the second-
ary neutrons depends on the energy of the incident protons
and can contain sufficient range to reach the patient and de-
posit dose outside the treatment volume. This undesired dose
from secondary neutrons could pose a significant risk factor for
developing a secondary cancer later in the life time since neu-
trons have higher relative biological effectiveness (RBE).5-6
Although the association between secondary cancer and neu-
trons dose is not yet well understood 7, the study of secondary
neutrons is important for the overall quality of treatment.
Currently, there are two types of beam delivery systems avail-
able: passive scattering and active scanning. In general, passive
scattering employs scattering material in the beam path for
dose conformity while active scanning employs scanning
magnets to irradiate the tumor volume. Active scanning sys-
tems are also classified into two categories 8 : a) pencil beam
scanning, and b) uniform scanning. The basic difference be-
tween these two categories is that the pencil beam scanning
system may not require any beam shaping components while
uniform scanning system requires beam shaping components.9
In addition, pencil beam scanning is capable of delivering a
beam of variable intensity during scanning, while uniform
scanning employs a beam of uniform intensity.8, 10, 11 In gen-
eral, the passive scattering system uses more beam shaping
components than that of active scanning system and presuma-
bly produces more secondary neutrons.
For the understanding of secondary radiation in proton radio-
therapy, a numerous studies have been performed and is con-
sidered to be a very active area of research. Both measure-
ments and numerical simulations have been conducted to de-
termine the secondary radiation for a greater number of sce-
narios to replicate the real life problem. A comparison of
available neutron study from various proton facilities help to
see the latest standing of this issue. It is to be noted that the
comparison of neutron dose among facilities are not exact as
the treatment condition, beam shaping components vary from
facility to facility.
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In 2002, Yan et al.12 reported 4.5 mSv/Gy of neutron dose for
passive scattering system @160 MeV proton beam for Harvard
Cyclotron Laboratory (HCL), 50 cm off-axis to the primary
beam. Using a pencil beam scanning approach, Schneider et
al.13 reported 0.12 mSv/Gy for 177 MeV proton beam at Paul
Scherrer Institute (PSI) Proton Therapy Facility, Switzerland.
Zheng et al.8 conducted a study for a uniform scanning system
at ProCure Proton Therapy Center, Oklahoma, USA.  For a 78
MeV proton beam, Zheng et al. reported 0.35 mSv/Gy at 50 cm
off-axis to the primary beam.8 Most recently, Islam et al.14
conducted a study for the uniform scanning system at ProCure
Proton Therapy Center, Oklahoma and also compared the
neutron dose among different facilities. According to Islam et
al.14, neutron dose ranged from 0.3 to 38 mSv/Gy for the pro-
ton energy ranges from 78 to 226 MeV. This data also reveals
that the dose from the uniform scanning system is comparable
with passive scattering system but greater than that of pencil
beam scanning system. The overall study for different scanning
mechanisms demonstrates that the neutron dose ranges from
0.1 to about 50 mSv/Gy for therapeutic proton energies. It is to
be noted that the uncertainty involved in neutron measure-
ment is generally high, and different measurement techniques
can also lead to a greater variation in the reported dose.
In summary, proton radiotherapy is becoming increasingly
important as an effective form of radiotherapy2, 15 but the ad-
vantage of proton radiotherapy could be suffered due to the
presence of secondary neutrons. It is true that the measure-
ment of dose and dose equivalent due to neutrons is not
straightforward as the neutrons interaction (cross section) with
common detecting material used in radiation detector is negli-
gible. But the determination of neutron dose due to primary
proton beam is important as neutrons have higher RBE. Fur-
thermore, the current treatment planning systems in proton
therapy do not include the dose contribution due to the sec-
ondary neutrons. In this context, the secondary neutrons pro-
duced in proton treatment facility should be assessed and
minimized as much as possible. Additionally, the neutron
study can help in improving the available radiation risk mod-
eling, which may assist the physicians to take informed deci-
sions.
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